457 related articles for article (PubMed ID: 10208143)
1. Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial.
Strawford A; Barbieri T; Van Loan M; Parks E; Catlin D; Barton N; Neese R; Christiansen M; King J; Hellerstein MK
JAMA; 1999 Apr; 281(14):1282-90. PubMed ID: 10208143
[TBL] [Abstract][Full Text] [Related]
2. Double-blind, randomized, placebo-controlled phase III trial of oxymetholone for the treatment of HIV wasting.
Hengge UR; Stocks K; Wiehler H; Faulkner S; Esser S; Lorenz C; Jentzen W; Hengge D; Goos M; Dudley RE; Ringham G
AIDS; 2003 Mar; 17(5):699-710. PubMed ID: 12646793
[TBL] [Abstract][Full Text] [Related]
3. Oxymetholone for the treatment of HIV-wasting: a double-blind, randomized, placebo-controlled phase III trial in eugonadal men and women.
Hengge UR; Stocks K; Faulkner S; Wiehler H; Lorenz C; Jentzen W; Hengge D; Ringham G
HIV Clin Trials; 2003; 4(3):150-63. PubMed ID: 12815555
[TBL] [Abstract][Full Text] [Related]
4. Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial.
Grinspoon S; Corcoran C; Askari H; Schoenfeld D; Wolf L; Burrows B; Walsh M; Hayden D; Parlman K; Anderson E; Basgoz N; Klibanski A
Ann Intern Med; 1998 Jul; 129(1):18-26. PubMed ID: 9652995
[TBL] [Abstract][Full Text] [Related]
5. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
Grinspoon S; Corcoran C; Lee K; Burrows B; Hubbard J; Katznelson L; Walsh M; Guccione A; Cannan J; Heller H; Basgoz N; Klibanski A
J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
[TBL] [Abstract][Full Text] [Related]
6. Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels.
Bhasin S; Storer TW; Javanbakht M; Berman N; Yarasheski KE; Phillips J; Dike M; Sinha-Hikim I; Shen R; Hays RD; Beall G
JAMA; 2000 Feb; 283(6):763-70. PubMed ID: 10683055
[TBL] [Abstract][Full Text] [Related]
7. Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss.
Strawford A; Barbieri T; Neese R; Van Loan M; Christiansen M; Hoh R; Sathyan G; Skowronski R; King J; Hellerstein M
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb; 20(2):137-46. PubMed ID: 10048900
[TBL] [Abstract][Full Text] [Related]
8. Testosterone supplementation of megestrol therapy does not enhance lean tissue accrual in men with human immunodeficiency virus-associated weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
Mulligan K; Zackin R; Von Roenn JH; Chesney MA; Egorin MJ; Sattler FR; Benson CA; Liu T; Umbleja T; Shriver S; Auchus RJ; Schambelan M;
J Clin Endocrinol Metab; 2007 Feb; 92(2):563-70. PubMed ID: 17090640
[TBL] [Abstract][Full Text] [Related]
9. Oxandrolone in the treatment of HIV-associated weight loss in men: a randomized, double-blind, placebo-controlled study.
Grunfeld C; Kotler DP; Dobs A; Glesby M; Bhasin S
J Acquir Immune Defic Syndr; 2006 Mar; 41(3):304-14. PubMed ID: 16540931
[TBL] [Abstract][Full Text] [Related]
10. Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial.
Grinspoon S; Corcoran C; Parlman K; Costello M; Rosenthal D; Anderson E; Stanley T; Schoenfeld D; Burrows B; Hayden D; Basgoz N; Klibanski A
Ann Intern Med; 2000 Sep; 133(5):348-55. PubMed ID: 10979879
[TBL] [Abstract][Full Text] [Related]
11. The use of testosterone in the AIDS wasting syndrome.
Corcoran C; Grinspoon S
AIDS Clin Care; 1999 Apr; 11(4):25-6, 33-4. PubMed ID: 11366208
[TBL] [Abstract][Full Text] [Related]
12. Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.
Hadigan C; Corcoran C; Stanley T; Piecuch S; Klibanski A; Grinspoon S
J Clin Endocrinol Metab; 2000 Jan; 85(1):35-41. PubMed ID: 10634360
[TBL] [Abstract][Full Text] [Related]
13. Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: A randomized, controlled trial.
Johansen KL; Painter PL; Sakkas GK; Gordon P; Doyle J; Shubert T
J Am Soc Nephrol; 2006 Aug; 17(8):2307-14. PubMed ID: 16825332
[TBL] [Abstract][Full Text] [Related]
14. Monitoring changes in fat-free mass in HIV-positive men with hypotestosteronemia and AIDS wasting syndrome treated with gonadal hormone replacement therapy.
Van Loan MD; Strawford A; Jacob M; Hellerstein M
AIDS; 1999 Feb; 13(2):241-8. PubMed ID: 10202830
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial.
Blackman MR; Sorkin JD; Münzer T; Bellantoni MF; Busby-Whitehead J; Stevens TE; Jayme J; O'Connor KG; Christmas C; Tobin JD; Stewart KJ; Cottrell E; St Clair C; Pabst KM; Harman SM
JAMA; 2002 Nov; 288(18):2282-92. PubMed ID: 12425705
[TBL] [Abstract][Full Text] [Related]
16. Body cell mass repletion and improved quality of life in HIV-infected individuals receiving oxandrolone.
Earthman CP; Reid PM; Harper IT; Ravussin E; Howell WH
JPEN J Parenter Enteral Nutr; 2002; 26(6):357-65. PubMed ID: 12405647
[TBL] [Abstract][Full Text] [Related]
17. A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment.
Storer TW; Woodhouse LJ; Sattler F; Singh AB; Schroeder ET; Beck K; Padero M; Mac P; Yarasheski KE; Geurts P; Willemsen A; Harms MK; Bhasin S
J Clin Endocrinol Metab; 2005 Aug; 90(8):4474-82. PubMed ID: 15914526
[TBL] [Abstract][Full Text] [Related]
18. Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting.
Grinspoon S; Corcoran C; Stanley T; Katznelson L; Klibanski A
J Clin Endocrinol Metab; 1998 Dec; 83(12):4251-6. PubMed ID: 9851759
[TBL] [Abstract][Full Text] [Related]
19. Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial.
Johansen KL; Mulligan K; Schambelan M
JAMA; 1999 Apr; 281(14):1275-81. PubMed ID: 10208142
[TBL] [Abstract][Full Text] [Related]
20. Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome.
Fairfield WP; Finkelstein JS; Klibanski A; Grinspoon SK
J Clin Endocrinol Metab; 2001 May; 86(5):2020-6. PubMed ID: 11344201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
